COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,724 Articles (22,502 medRxiv, 8,222 bioRxiv)

Most recent first Previous |  Page 198: Articles 1971-1980  | Next

Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms
Suzuki, M., Okamura, S., Gis, T., Sasaki, H., Lee, S., Yoshida, A., Goto, S., Nakagawa, T., Ikawa, M., Kamitani, W., Takekawa, S., Yamanishi, K., Ebina, H.
10.1101/2024.03.03.582873 — Posted: 2024-03-04
Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough infection
He, X., Jiang, J., Li, G., Liu, J., Gan, J., Zhou, L., Bai, C., Zi, Q., Mou, X., Zeng, S., Yuan, J., Zhou, C., Li, Y., Zhu, G., Zhao, R., Yang, L., Wu, J., Zhang, H., Xian, J., Wang, Z., Qi, Q., Liu, Y., Yu, J., Liu, D., Li, W.
10.1101/2024.03.02.583082 — Posted: 2024-03-04
Physics-driven structural docking and protein language models accelerate antibody screening and design for broad-spectrum antiviral therapy
Mubarak, H. F., Tan, W., Hoffmann, A. D., Wei, J., El-Shennawy, L., Squires, J. R., Sun, Y., Dashzeveg, N. K., Simonton, B., Jia, Y., Iyer, R., Xu, Y., Nicolaescu, V., Elli, D., Randall, G. C., Schipma, M. J., Swaminathan, S., Ison, M. G., Liu, H., Fang, D., Shen, Y.
10.1101/2024.03.01.582176 — Posted: 2024-03-04
Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate AVX/COVID-12 Activates T Cells and Is Recognized by Antibodies from COVID-19 Patients and Vaccinated
Torres-Flores, A., Ontiveros-Padilla, L. A., Madera-Sandoval, R. L., Tepale-Segura, A., Gajon-Martinez, J., Rivera-Hernandez, T., Ferat-Osorio, E. A., Cerbulo-Vazquez, A., Arriaga-Pizano, L. A., Bonifaz, L., Paz-De la Rosa, G., Rojas-Martinez, O., Suarez-Martinez, A., Peralta-Sanchez, G., Sarfati-Mizrahi, D., Sun, W., Chagoya-Cortes, H. E., Palese, P., Krammer, F., Garcia-Sastre, A., Lozano-Dubernard, B., Lopez-Macias, C.
10.1101/2024.03.01.582987 — Posted: 2024-03-04
B cell maturation restored ancestral germlines to control Omicron BA.2.86
Paciello, I., Pierleoni, G., Pantano, E., Antonelli, G., Pileri, P., Maccari, G., Cardamone, D., Realini, G., Perrone, F., Neto, M. M., Pozzessere, S., Fabbiani, M., Panza, F., Rancan, I., Tumbarello, M., Montagnani, F., Medini, D., Maes, P., Temperton, N. J., Simon-Loriere, E., Schwartz, O., Rappuoli, R., Andreano, E.
10.1101/2024.03.03.583187 — Posted: 2024-03-04
Time-dependent enhancement of mRNA vaccines by 4-1BB costimulation
Sanchez, S., Dangi, T., Awakoaiye, B., Irani, N., Fourati, S., Richner, J. M., Penaloza-MacMaster, P.
10.1101/2024.03.01.582992 — Posted: 2024-03-04
SARS-CoV-2 diversity and transmission on a university campus across two academic years during the pandemic
Casto, A. M., Paredes, M. I., Bennett, J. C., Luiten, K. G., O'Hanlon, J. A., Han, P. D., Gamboa, L., McDermot, E., Truong, M., Gottlieb, G. S., Acker, Z., Wolf, C. R., Magedson, A., Lo, N. K., McDonald, D., Wright, T. C., McCaffrey, K., Figgins, M. D., Englund, J. A., Boeckh, M., Lockwood, C. M., Nickerson, D. A., Shendure, J., Uyeki, T. M., Starita, L. M., Bedford, T., Chu, H. Y., Weil, A. A.
10.1101/2024.02.29.24303285 — Posted: 2024-03-02
Sex differences in symptomatology and immune profiles of Long COVID
Silva, J., Takahashi, T., Wood, J., Lu, P., Tabachnikova, S., Gehlhausen, J., Greene, K., Bhattacharjee, B., Silva Monteiro, V., Lucas, C., Dhodapkar, R., Tabacof, L., Pena-Hernandez, M., Kamath, K., Mao, T., Mccarthy, D., Medzhitov, R., van Dijk, D., Krumholz, H., Guan, L., Putrino, D., Iwasaki, A.
10.1101/2024.02.29.24303568 — Posted: 2024-03-02
Age-Specific All-Cause Mortality Disparities by Race and Ethnicity During the COVID-19 Pandemic
Faust, J. S., Renton, B., Bongiovanni, T., Chen, A. J., Sheares, K. D., Du, C., Essien, U. R., Fuentes-Afflick, E., Haywood, T. T., Khera, R., King, T., Li, S.-X., Lin, Z., Lu, Y., Marshall, A. D. A., Ndumele, C. D., Opara, I., Loarte-Rodriguez, T., Sawano, M., Taparra, K., Taylor, H. A., Watson, K. E., Yancy, C. W., Krumholz, H. M.
10.1101/2024.03.01.24303592 — Posted: 2024-03-02
Increased luminal area of large conducting airways in patients with COVID-19 and post-acute sequelae of COVID-19 A retrospective case-control study
Zaremba, S., Miller, A. J., Ovrom, E. A., Senefeld, J. W., Wiggins, C. C., Dominelli, P. B., Ganesh, R., Hurt, R. T., Bartholmai, B. J., Welch, B. T., Ripoll, J. G., Joyner, M. J., Ramsook, A. H.
10.1101/2024.02.29.24303556 — Posted: 2024-03-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).